Sodium valproate and metyrapone for pituitary-dependent Cushing's disease.
D000311:Adrenal Glands / Q000187:drug effects; D000328:Adult; D003480:Cushing Syndrome / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008797:Metyrapone / Q000008:administration & dosage*; D010902:Pituitary Gland / Q000187:drug effects*; D014635:Valproic Acid / Q000008:administration & dosage*
D014635:Valproic Acid; D008797:Metyrapone